Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous and Allogeneic BMT for Low Grade Lymphoma
NCT00002829Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 1994
- Primary completion
- Apr 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in lymphoma, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 1994; status: completed.
02
Drugs
interferon alfa
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT00002829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002829.